Suchergebnisse - "Lu, Jianming"

PubPharm (212)

1

Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer : A benchmarking study using ten machine learning methods and twelve patient cohorts

enthalten in: Cancer letters | 2024

von Yin, W. | Chen, G. | Li, Y. | +10

2

Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane

enthalten in: bioRxiv.org | 2024

von Shi, W. | Cai, Y. | Zhu, H. | +10

3

Lamin B1 : a novel biomarker in adult and pediatric adrenocortical carcinoma

enthalten in: Endocrine-related cancer | 2024

von Chen, Y. | Chen, J. | Shi, Y. | +8

4

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

enthalten in: Frontiers in pharmacology | 2024

von Maen, A. | Gok Yavuz, B. | Mohamed, Y. | +12

5

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation

enthalten in: Cell death & disease | 2024

von Liu, R. | Zou, Z. | Chen, L. | +16

6

Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases

enthalten in: Molecular therapy oncolytics | 2023

von Yang, A. | Zhang, Z. | Chaurasiya, S. | +6

7

Marker for diagnosis, treatment and prognosis evaluation of prostate cancer and application of marker

enthalten in: Europäisches Patentamt | 2023

von CAI CHAO | LIN ZHUOYUAN | LU JIANMING | +1

8

Antibody-mediated SARS-CoV-2 entry in cultured cells

enthalten in: EMBO reports | 2023

von Kibria, M. | Lavine, C. | Tang, W. | +14

9

Construction method and application of mLs model based on LncRNA

enthalten in: Europäisches Patentamt | 2023

von CAI CHAO | LIN ZHUOYUAN | LU JIANMING | +1

10

N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer

enthalten in: Human genetics | 2023

von Liang, Y. | Yin, W. | Cai, Z. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]